| Mono Pharmacare Ltd | Industry : Pharmaceuticals | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | |||
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 17.67 | 17.67 | 12.37 | ||
| Reserves | 13.53 | 10.44 | 1.03 | ||
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | ||
| Equity Application Money | 0.00 | 0.00 | 0.00 | ||
| Total Shareholders Funds | 31.20 | 28.11 | 13.40 | ||
| Secured Loans | 11.80 | 13.16 | 10.00 | ||
| Unsecured Loans | 11.89 | 0.11 | 2.51 | ||
| Total Debt | 23.69 | 13.27 | 12.51 | ||
| Other Liabilities | 0.08 | 0.04 | 0.00 | ||
| Total Liabilities | 54.97 | 41.42 | 25.91 | ||
| APPLICATION OF FUNDS : | |||||
| Gross Block | 0.41 | 0.24 | 0.21 | ||
| Less: Accumulated Depreciation | 0.18 | 0.10 | 0.02 | ||
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | ||
| Net Block | 0.23 | 0.14 | 0.19 | ||
| Lease Adjustments | 0.00 | 0.00 | 0.00 | ||
| Capital Work in Progress | 0.02 | 0.00 | 0.00 | ||
| Investments | 10.84 | 3.59 | 1.97 | ||
| Current Assets, Loans & Advances | |||||
| Inventories | 27.79 | 20.99 | 15.18 | ||
| Sundry Debtors | 18.90 | 17.44 | 8.08 | ||
| Cash and Bank Balance | 0.11 | 0.25 | 0.23 | ||
| Loans and Advances | 8.14 | 2.96 | 3.35 | ||
| Total Current Assets | 54.94 | 41.64 | 26.84 | ||
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 10.21 | 3.71 | 2.71 | ||
| Provisions | 0.88 | 0.27 | 0.45 | ||
| Total CL & Provisions | 11.09 | 3.98 | 3.16 | ||
| Net Current Assets | 43.85 | 37.66 | 23.68 | ||
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | ||
| Deferred Tax Assets | 0.04 | 0.02 | 0.05 | ||
| Deferred Tax Liability | 0.00 | 0.01 | 0.00 | ||
| Net Deferred Tax | 0.04 | 0.01 | 0.05 | ||
| Other Assets | 0.01 | 0.01 | 0.01 | ||
| Total Assets | 54.98 | 41.41 | 25.90 | ||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 |